Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
A Child with Delayed Motor Milestones and Ptosis
Neurol 88:e158-e163, Ghosh, P.S., 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014
Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005
Adult Botulism
Muscle & Nerve, 20:100-10297., Shapiro,B.E.,et al, 1997
Botulinum Toxin:A Deadly Poison Sheds its Negative Image
Ann Int Med 125:616-617, Simpson,L.L., 1996
Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994
4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome
JNNP 40:1109, Lundh,H.,et al, 1977
Multiple Sclerosis Associated with Defects in Neuromuscular Transmission
JNNP 35:385, Patten,B.M.,et al, 1972
Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999
Adverse Effects of Magnesium Salt Cathartics in a Patient with the Myasthenic Syndrome (Lambert-Eaton Syndrome)
Ann Neurol 2:175, Streib,E.W., 1977
Histometric Anal. of Ultra-structure of Neuromuscular Junct. in Myasthenia Gravis & in the Myasthenic Syndr
Ann N Y Acad Sci 186:46, Engel,A.,et al, 1971
Myasthenic Syndrome in Patients with ALS
et al Neurol 9:627, Mulder,D.W., 1959